Quantcast

Latest Interventional cardiology Stories

2014-03-28 12:26:29

Supera Stent Addresses Growing Need in the U.S. to Treat People with Blocked Blood Vessels and Restore Blood Flow in the Upper Leg ABBOTT PARK, Ill., March 28, 2014 /PRNewswire/ -- Abbott today announced that its Supera(®) Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD). PAD occurs when fat and cholesterol buildup causes arteries outside of the...

2014-03-25 16:25:35

DUBLIN, Mar. 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/k8gx4n/china ) has announced the addition of the "Concise Analysis of the International Interventional Cardiovascular Device Industry" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning...

2014-03-24 20:23:55

DALLAS, March 25, 2014 /PRNewswire/ -- The report "Pediatric Interventional Cardiology Market by Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, APAC, and the Rest of the World. Browse more than 90 Market Data...

2014-03-24 20:23:53

Second Generation drug coated balloon designed to address both acute and long-term outcomes PLEASANTON Calif. and SINGAPORE, March 24, 2014 /PRNewswire/ -- TriReme Medical LLC, a subsidiary of Singapore based QT Vascular Ltd. announced today that the first three patients were enrolled in a clinical study of its unique drug-coated Chocolate® PTA balloon. Dr. Andrew Holden, co-Principal Investigator of the study, performed these procedures at Auckland City Hospital, in Auckland, New...

2014-03-17 16:28:56

PLEASANTON, Calif., March 17, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II(®) LVAS Pocket System Controller (the "Pocket Controller"). The following information is provided as a reinforcement of the initial release. Failure to completely connect the driveline during the process of exchanging Pocket System Controllers has resulted in serious...

2014-03-13 23:29:08

Program envisions enabling remote robotic-assisted PCI for patients in rural areas. Waltham, MA (PRWEB) March 13, 2014 Corindus Vascular Robotics (http://www.corindus.com/), a leading developer of precision vascular robotics and provider of the CorPath Vascular Robotic System, today announced a partnership with Sanford Health and The Leona M. and Harry B. Helmsley Charitable Trust to launch a feasibility investigation for a remote robotics program. For many patients living in rural areas,...

2014-03-12 20:24:27

Newest Bare Metal Stent Technology Features Advanced Architecture and Provides Physicians with Enhanced Treatment Option for Patients NATICK, Mass., March 12, 2014 /PRNewswire/ -- Continuing to advance leading stent technology, Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the REBEL(TM) Platinum Chromium Coronary Stent System, the company's latest generation bare metal stent for the treatment of coronary artery disease (CAD). Developed to expand the...

2014-03-11 16:26:25

Once Results of Studies Are Approved by the FDA, the Smaller 50cc SynCardia Heart and New Permanent Use Indication Will Triple the Number of Heart Failure Patients Who Can Get a 2nd Chance at Life TUCSON, Ariz., March 11, 2014 /PRNewswire/ -- Recent developments surrounding the SynCardia temporary Total Artificial Heart will make the life-saving device available to three times the number of people suffering from end-stage biventricular heart failure. Over 300 SynCardia Hearts have...

2014-03-07 08:26:22

FRAMINGHAM, Mass., March 7, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel. A live webcast of...

2014-03-06 12:26:53

Increasing Presence of Domestic Competitors Will Undercut Prices Set by Multinational Companies, According to Findings from Decision Resources Group BURLINGTON, Mass., March 6, 2014 /PRNewswire/ -- Decision Resources Group finds that growth in the Chinese market for interventional cardiology (IC) devices has slowed dramatically compared to previous years due to increasing competition from domestic competitors. Smaller local competitors are looking to enter the drug-eluting stent...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.